Flot.bio

New episode from Munich 🇩🇪: here’s my conversation with Dominik Schumacher of Tubulis GmbH, best founders under 40 🚀 Gain insights from a “true” biotech founder, one of the only founder-PhDs under 40 that have scaled to raise over 100M. “There’s a lot of ADC development happening [in China] and the quality is really good. It’s competition that we look at seriously and take seriously.” We talked about building a champion ADC biotech, took a deep dive into the ADC sphere, and the difference between luck and success. You can now watch and listen to the full episode for free on YouTube, Spotify or Apple (link in the comments). What do you think? 🤔

Glad to be in Munich 🇩🇪 to finally meet Dominik Schumacher offline and record an episode 🙌 We talked about founder-led biotechs, especially founded by PhDs under 40, and at scale (€100M+ raised). We also talk about ADCs with Tubulis GmbH and what’s the role of luck in biotech successes. Full episode will be online next week ⏰

Here’s a teaser to a new episode with one of the top VCs: Otello Stampacchia of Omega Funds 🙌 Learn why now is the highest competitive tension in biopharma that he has ever seen. “Lessons learned, I should have probably moved to the US earlier because it would have allowed us to scale the organisation and the fundraising faster.” We further discuss his career, especially the challenges and opportunities that came from moving to Boston over 15 years ago. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

Good to be back in Boston 🇺🇸 to finally meet and record an episode offline with top VC Otello Stampacchia 🙌 He has a deep European background and connection. On top of having had many exits, especially in the last two years (>10!!), he's a super chilled and fun person (first guest in short on the show 😎). We talked about the highest competitive tension in biopharma now that he has ever seen. We also talked about his career, especially the challenges and opportunity he had from moving to Boston over 15 years ago. Full episode released next week ⏰ Omega Funds

Here’s a teaser to a new episode with one of the top female VCs in Europe: Christina Takke from V-Bio Ventures. Be inspired by her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. “When you have different views you start a discussion with each other, you look at investment opportunities from different angles.” We also talk about her investment in Argenx when it was only three employees and the venture creation drop since 2022. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

"The newer investors...deciding 'wow this is a new technology and... if they can do it in ALS they can do it in other CNS diseases." This short clip comes from our chat with Sander van Deventer of VectorY where he shares how he raised Europe's largest biotech series A of 2023. "With that shift in perception means also the potential is bigger." An inspiring story 🚀 You can find more short clips of past interviews on YouTube.

"I will not take people's money unless I have to." Here's a short clip from our chat with Johannes Fruehauf of BioLabs. Pulling from his own experience, he shares some counterintuitive advice for biotech startups looking to raise money. "It's not a bad thing to take other partners into your business to provide capital as long as you have a good arrangement." Do you agree with him? You can find more short clips of past interviews on YouTube.

Here’s a teaser to the first open-air episode from San Sebastián 🇪🇸 with Naveed Siddiqi of one of the world’s largest biotech investors (Novo Holdings). Discover what things are really like in European biotech at the moment. “Multiple billion $ companies and multiple billion $ exits, we need more of that in Europe, and that needs scale capital.” We also talked about his upbringing as a second-generation immigrant in the UK and the importance of diversity. I’ve known him since he was a partner at Andera. He is a sharp investor, but also very friendly and open. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

Another milestone reached! We're celebrating our first 15 amazing guests 🎉 We've had such a great time learning from all these incredible minds and stories and can't wait to do more. We already have 3 episodes waiting in the pipeline for you 😉 Who has been your favourite so far?

Great to finally meet Naveed Siddiqi live for the first open air recording of the show in San Sebastian ☀️🇪🇸🙌 We talked about the real macro picture of European biotech, seen through his lenses at Novo ($500M invested per year, top 3 globally). We also talked about his upbringing as second gen immigrant in the UK and the importance of diversity. Full episode will be released later this month 📆 #BioEquity #Novo